BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16474408)

  • 1. Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis - was Demodex the culprit?
    Lotze C; Krüger WH; Kiefer T; Swensson O; Herbst EW; Schüler F; Busemann C; Dölken G
    Bone Marrow Transplant; 2006 Apr; 37(7):711-2. PubMed ID: 16474408
    [No Abstract]   [Full Text] [Related]  

  • 2. Demodicidosis simulating acute graft-versus-host disease after allogeneic stem cell transplantation in one patient with acute lymphoblastic leukemia.
    Román-Curto C; Meseguer-Yebra C; Cañueto J; Fraile-Alonso C; Santos-Briz A; Vázquez L; Fernández-López E
    Transpl Infect Dis; 2012 Aug; 14(4):387-90. PubMed ID: 22487272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
    Kröger N; Thiele J; Zander A; Schwerdtfeger R; Kobbe G; Bornhäuser M; Bethge W; Schubert J; de Witte T; Kvasnicka HM;
    Exp Hematol; 2007 Nov; 35(11):1719-22. PubMed ID: 17976523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demodex folliculitis mimicking acute graft-vs-host disease.
    Cotliar J; Frankfurt O
    JAMA Dermatol; 2013 Dec; 149(12):1407-9. PubMed ID: 24132559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
    de Lavallade H; Faucher C; Fürst S; El-Cheikh J; Vey N; Coso D; Bouabdallah R; Stoppa AM; Gastaut JA; Blaise D; Mohty M
    Bone Marrow Transplant; 2006 Apr; 37(7):709-10. PubMed ID: 16474410
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.
    Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH
    Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia.
    Ozdemir E; Molldrem JJ
    Bone Marrow Transplant; 2006 Apr; 37(8):785-6. PubMed ID: 16501592
    [No Abstract]   [Full Text] [Related]  

  • 8. What is your diagnosis? Demodex folliculitis.
    Weingartner JS; Allen PS
    Cutis; 2012 Aug; 90(2):62, 65-6, 69. PubMed ID: 22988646
    [No Abstract]   [Full Text] [Related]  

  • 9. Gelatinous degeneration in a recipient of allogeneic bone marrow transplantation.
    Aisa Y; Mori T; Nakazato T; Yamazaki R; Ikeda Y; Okamoto S
    Int J Hematol; 2006 Dec; 84(5):465-7. PubMed ID: 17189232
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.
    Min CK; Kim SY; Lee MJ; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC; Cho CS
    Bone Marrow Transplant; 2006 Jul; 38(2):149-56. PubMed ID: 16751784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.
    Valcárcel D; Martino R; Piñana JL; Sierra J
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G; Clark RE; Crawley C; Mackinnon S; Russell N; Thomson K; Pearce RM; Towlson K; Marks DI
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):293-300. PubMed ID: 16503498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
    J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical early follicular graft-vs-host disease.
    Goiriz R; Delgado-Jiménez Y; Fernández-Peñas P; Fraga J; García-Diez A; Fernández-Herrera J
    Arch Dermatol; 2006 Sep; 142(9):1237-8. PubMed ID: 16983021
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using capsule endoscopy to diagnose graft-versus-host disease: seeing is believing?
    Eisen GM
    Gastrointest Endosc; 2007 Mar; 65(3):410-1. PubMed ID: 17321240
    [No Abstract]   [Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular graft-versus-host disease: a rare manifestation of chronic cutaneous graft-versus-host disease.
    Martí N; Martin JM; Monteagudo C; López V; Jordá E
    Am J Dermatopathol; 2008 Dec; 30(6):620-1. PubMed ID: 19033942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.